Company Analysis

Incannex Healthcare Inc. (IXHL)

Nasdaq: IXHL · Pharmaceutical Preparations · filing with the SEC since 2021
Grade4.2
◀ Past 2.1● Present 4.5▶ Future 5.3
5 est.

Filings

244 filings since 2017 beside 23 insider forms · Non-accelerated filer and smaller reporting company and emerging growth company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company and emerging growth company
10-Q Quarterly report for the quarter ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Feb 14, 2027
10-K Annual report for the fiscal year ending Jun 30, 2027Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Sep 28, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Oct 28, 2026.

Filings a yearinsider forms included
73872437631
202120222023202420252026

2026 counts to Nov 13, 2026.

Listing warning from its exchange (8-K item 3.01): 6 times in the last 36 months, the newest Mar 17, 2026.Officer or director change (8-K item 5.02): 4 times in the last 36 months, the newest May 28, 2025.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Dec 15, 2023.SEC letters: 9 in the last 36 months, the newest Apr 29, 2025.
Insider forms 23

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 10-Q Quarterly report Sep 30, 2026
Oct 28, 2026 ARS Annual report to shareholders Jun 30, 2026
Oct 28, 2026 DEFA14A Extra proxy material
Oct 28, 2026 DEF 14A Proxy statement Dec 17, 2026
Sep 25, 2026 10-K Annual report Jun 30, 2026
Sep 9, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 25, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 14, 2026 SCHEDULE 13G Large holder notice
Aug 11, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jul 23, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jun 25, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jun 10, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jun 9, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
May 15, 2026 10-Q Quarterly report Mar 31, 2026
May 14, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
May 12, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Apr 22, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Mar 27, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Mar 25, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Mar 18, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Mar 17, 2026 8-K items 3.01, 8.01, 9.01 Listing warning from its exchange; Other event · Current report Mar 16, 2026
Mar 12, 2026 424B5 Shelf offering
Mar 12, 2026 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report
Mar 12, 2026 8-K items 1.02, 7.01, 8.01, 9.01 Major agreement ended; Investor disclosure (Regulation FD); Other event · Current report Mar 11, 2026
Feb 25, 2026 8-K items 3.03, 5.03, 8.01, 9.01 Change to shareholders' rights; Charter, bylaw or fiscal-year change; Other event · Current report Feb 24, 2026
Feb 13, 2026 10-Q Quarterly report Dec 31, 2025
Jan 29, 2026 8-K items 8.01, 9.01 Other event · Current report
Jan 22, 2026 8-K items 8.01, 9.01 Other event · Current report
Jan 16, 2026 8-K item 5.07 Shareholder vote · Current report Jan 15, 2026
Jan 15, 2026 8-K items 8.01, 9.01 Other event · Current report
Jan 14, 2026 8-K items 8.01, 9.01 Other event · Current report
Dec 18, 2025 8-K item 8.01 Other event · Current report
Dec 18, 2025 DEFA14A Extra proxy material
Dec 16, 2025 DEFA14A Extra proxy material
Dec 3, 2025 8-K items 8.01, 9.01 Other event · Current report
Nov 14, 2025 10-Q Quarterly report Sep 30, 2025
Nov 14, 2025 S-8 Employee stock plan registration
Oct 30, 2025 8-K items 8.01, 9.01 Other event · Current report
Oct 27, 2025 ARS Annual report to shareholders Jun 30, 2025
Oct 27, 2025 DEFA14A Extra proxy material
40 of 244 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton IXHL · research, not advice